Alergical SF

Quick links to important sections

Alergical SF

Method of action: Antitussive, Antitussive Opioid

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Alergical SF

Property Description
Active Ingredient Chlorpheniramine, Pseudoephedrine
Form Oral Solution, Tablet, Capsule
Pharmacological Class Antihistamine and Sympathomimetic combination
General Purpose Symptomatic relief of congestion and allergy signs
Origin Synthetic

What is Alergical SF and Its Classification?

Alergical SF is a synthetic Fixed-Dose Combination (FDC) Medication formulated for Oral administration, designed to provide relief from symptoms associated with allergies and common upper respiratory issues. It is classified as an Antihistamine and Sympathomimetic combination product. This preparation is strategically used to address the multiple concurrent symptoms of allergic rhinitis, distinguishing it from single-agent drugs. The FDC nature allows for a unified therapeutic approach to managing both the allergic response and physical congestion.


Composition and Differentiating Features

The product's identity is defined by its two primary active ingredients: Chlorpheniramine and Pseudoephedrine. Chlorpheniramine, a first-generation antihistamine, functions as an H1 antagonist, which is the mechanism used to minimize allergic responses in the body. Pseudoephedrine is classified as a sympathomimetic decongestant, providing relief by causing vasoconstriction, or the narrowing of blood vessels in the nasal passages. As an oral solution, Alergical SF offers the practical advantage of easier administration for individuals who may have difficulty swallowing solid dosage forms.


General Therapeutic Purpose

The overall general purpose of this combination medicine is to alleviate the typical burden of respiratory discomfort, such as persistent nasal stuffiness and frequent sneezing. Its action provides symptomatic relief by combining the minimization of the allergic response with the reduction of nasal tissue swelling. This combined therapeutic approach helps to restore normal upper airway function, which is a key goal in managing the symptoms of allergic rhinitis and the common cold.

What side effects are possible with Alergical SF?

Possible side effects and safety information

The safety profile of Alergical SF, an antihistamine and sympathomimetic combination, is formally documented by regulatory authorities. Adverse reactions are grouped by the affected body system, reflecting the known actions of its two components.


Key Regulatory Classifications

System-Organ Class Common Adverse Reactions
Nervous System Drowsiness, Excitability, Sleeplessness, Headache, Dizziness
Gastrointestinal Dry mouth, Nausea, Upset stomach, Constipation
Cardiovascular Hypertension, Palpitations, Tachycardia

Serious Adverse Reactions and Safety Constraints

The combination medicine carries officially documented risks of serious adverse reactions. These include the potential for Hypertensive Crisis or severe cardiovascular events due to the sympathomimetic component, as well as documented rare, severe reactions such as Ischaemic Colitis, Posterior Reversible Encephalopathy Syndrome (PRES), and severe cutaneous reactions. These events, though infrequent, are explicitly listed in regulatory labeling.

Population-Specific Safety Notes emphasize that Excitability and nervousness are noted to occur specifically in the pediatric population. The medicine is subject to high-level safety restrictions and should not be used in individuals with pre-existing conditions such as severe hypertension, coronary artery disease, or closed-angle glaucoma, as these conditions can be exacerbated by its components. Safety documentation also prohibits its use with or within two weeks of stopping a Monoamine Oxidase Inhibitor (MAOI).

Overdose and Emergency Response

Overdose and When to Seek Help

Any suspected overdose of Alergical SF requires seeking immediate medical attention. The official overdose profile is documented by manifestations primarily affecting the Central Nervous System (CNS) and Cardiovascular system, reflecting the properties of its active ingredients. CNS effects may include a spectrum from severe sedation and drowsiness to paradoxical excitation, toxic psychosis, hallucinations, and confusion. Cardiovascular manifestations often documented are tachycardia, palpitations, cardiac arrhythmias, and hypertension, along with other signs such as difficulty in micturition.

Severe Outcomes and Urgent Action

Regulator-documented severe outcomes can include life-threatening events such as convulsions (seizures), apnoea, and cardiovascular collapse. Specific symptoms mandate contacting emergency services immediately: these include sudden severe or "thunderclap" headache, new-onset confusion, seizures, or symptoms suggestive of Acute Coronary Syndrome (sudden chest pain). Management is strictly symptomatic and supportive, as no specific antidote is known. Hospital monitoring of cardiac, respiratory, renal, and hepatic function is required. For recent or gross overdose, procedures such as activated charcoal or airways protective gastric lavage may be considered by medical professionals.

Population Considerations

Regulatory information specifies that overdose hazards are potentially greater in children and the elderly. These populations are cited as being more susceptible to certain neurological effects, including paradoxical excitation.

Therapeutic Uses of Alergical SF

Alergical SF is a combination medication commonly used for symptomatic relief across domains of upper respiratory discomfort. It is applied in addressing symptom clusters that may become intense or disruptive, aiming to contribute to easing the overall symptom load and helps improve day-to-day comfort during symptomatic periods. The combination is indicated for the temporary relief of symptoms associated with hay fever, allergies, and the common cold.


Managing Allergic and Nasal Irritation

This medication is generally used to help manage the challenging manifestations of Allergic Rhinitis and is applicable in conditions characterized by periods of heightened symptoms. It helps address symptom clusters that include frequent sneezing, runny nose, and itching of the nose, throat, or eyes. It may assist in providing symptomatic relief, which helps patients cope more steadily with these distressing manifestations.

“The combination may assist in providing supportive relief during episodes where multiple respiratory symptoms coexist.”

Easing Nasal and Sinus Congestion

Alergical SF is applied in clinical presentations where patients experience nasal congestion or a blocked nose, which often involves associated sinus pressure. It is often used during phases when symptoms become more noticeable, particularly when they interfere with daily comfort. It may provide short-term symptomatic assistance, which contributes to temporary functional relief, and is relevant for easing the discomfort associated with restricted upper airway function.


Quick Fact: Symptomatic support for Clustering Symptoms (This combination is relevant when a patient experiences multiple, concurrent symptoms related to a cold or allergy flare-up).

Regulatory References

  1. NIH DailyMed drug information

Eligibility and Restrictions for Use

Alergical SF eligibility is defined by strict regulatory guidelines regarding age, coexisting medical conditions, and concurrent medications. The medicine is generally established for use in adults and adolescents 12 years and older.

Populations Strictly Prohibited

The medicine is contraindicated and must not be used by patients with known hypersensitivity to the ingredients, those taking Monoamine Oxidase Inhibitors (MAOIs) within the last 14 days, or individuals with severe, uncontrolled hypertension, severe coronary artery disease, narrow angle glaucoma, or urinary retention.

Restricted Use and Special Caution

Age-related limitations are significant: the product is prohibited for use in children younger than four years of age, and use is strongly advised against in children under 12. Use in older adults (65 years and over) requires caution.

Use is restricted or requires specific medical guidance for individuals with conditions such as diabetes, thyroid disease, or moderate hepatic or renal impairment. Pregnancy use is generally advised to be avoided, particularly in the first trimester. Breastfeeding is not recommended due to the potential for the components to decrease milk supply and pass into breast milk.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Alergical SF has documented interactions with specific types of medicines and products that may affect how the medicine works or increase the risk of side effects. Official regulatory information highlights several categories of concern.

Drug-Drug and Drug-Product Categories

Interaction Category Examples of Interacting Substances
Central Nervous System (CNS) Depressants Alcohol, Sedatives, Opioid Pain Relievers
Specific Enzyme Inhibitors Ketoconazole, Erythromycin, Cimetidine
Products Affecting Absorption Antacids containing Aluminum or Magnesium

Practical Implications and Constraints

The co-administration of Alergical SF with CNS depressants may lead to additive effects, which necessitates caution. If use is required, monitoring by a healthcare professional is essential.

Combining Alergical SF with specific enzyme inhibitors (like Ketoconazole) can reduce the breakdown of Alergical SF in the body, leading to significantly higher levels of the medication. This may require an adjustment or an alternative treatment approach.

Finally, the product’s absorption can be reduced when taken with certain antacid preparations. Regulatory guidance specifies that a minimum separation of two hours between taking Alergical SF and these antacids is required to maintain effectiveness.

Mechanism of Action

The pharmacodynamic action of Alergical SF engages two distinct physiological control systems. Chlorpheniramine acts as an H1 receptor inverse agonist, stabilizing the receptor and functionally blocking the Gq-signaling cascade initiated by histamine. This H1 antagonism is coupled to reduced capillary permeability and a decreased rate of plasma extravasation into peripheral tissues. Concurrently, Pseudoephedrine, a mixed-acting sympathomimetic, targets alpha1-adrenergic receptors on vascular smooth muscle. This promotes vasoconstriction, driving the reduction of mucosal tissue volume by decreasing localized blood flow. The synergy between the H1 pathway inhibition and the autonomic vascular control facilitates the simultaneous inhibition of H1-mediated fluid extravasation and physical reduction of mucosal tissue volume. Additionally, the high lipophilicity of Chlorpheniramine enables its modulation of central H1 receptors and non-selective antagonism at central muscarinic acetylcholine receptors, which dictates the mechanism-dependent modulation of central nervous system activity.

Dosage and Administration Information

How to Use Alergical SF (Fexofenadine) — Official Administration Guidelines

This information is based strictly on regulatory documents, outlining the approved procedural steps for taking Alergical SF, which contains fexofenadine hydrochloride.

Administration Scope Detail
Route of Administration Oral (by mouth).
Timing in Relation to Meals Tablets may be taken with or without food, but they must be taken with water.
Dosing Schedule The standard regimen is typically Once Daily (QD) (e.g., 180 mg) or Twice Daily (BID) (e.g., 60 mg) depending on the dose and age group.
Preparation Requirements If using the oral suspension (liquid form), it must be shaken well before each dose, and the prescribed amount must be measured using a calibrated device.

Age-Group and Special Population Instructions

Population Standard Dosing Rule
Adults and Children ge 12 Years 180 mg QD or 60 mg BID.
Children 6 to 11 Years 30 mg BID.
Patients with Renal Impairment A reduced dose (e.g., 60 mg QD for adults) is required and should be followed strictly as prescribed.

Critical Administration Conditions

To ensure proper absorption and effectiveness, this medicine must not be consumed with fruit juices, including grapefruit, orange, or apple juice, as these can interfere with the drug's uptake. Additionally, the administration should be separated by at least two hours from the intake of antacids that contain aluminum or magnesium. If a dose is missed, take the next dose at the regular scheduled time; do not double the dose to compensate for the missed one.

Recent Clinical Evidence

Alergical SF: Recent Clinical Evidence

Evidence for Symptomatic Relief in Acute Conditions

The research base for the components of Alergical SF primarily consists of short-term Randomized Controlled Trials (RCTs). These studies were conducted to explore its use in managing acute, symptomatic phases of conditions like seasonal allergic rhinitis (hay fever) and the common cold.

In trials focused on allergic rhinitis, researchers monitored patient-reported outcomes for perceived discomfort, such as the severity of sneezing and runny nose, and used objective measurements to assess nasal function. For common cold studies, the focus was on changes in Total Symptom Scores (TSS) and specific congestion ratings over short durations. The findings describe patterns observed in the study populations, indicating how symptoms evolved over defined time intervals following administration.


Limitations and Areas of Research Uncertainty

The evidence for this combination is characterized by its short duration. Follow-up in most trials was limited, typically assessing effects within the first few hours up to one week. Consequently, long-term effects are not fully established, and there is limited information for outcomes related to continuous use over many weeks or months.

A significant portion of the evidence relies on subjective symptom scoring. Furthermore, comparative evidence is lacking for certain scenarios. The research overall highlights what is known—and what is still uncertain—about short-term outcomes for acute respiratory symptoms.


Evidence in Specific Age Groups

The clinical evidence was observed in both adults and some pediatric age groups, including adolescents and older children. However, the results apply only to the populations studied. Data for certain groups, such as the older adult population or patients presenting with complex comorbidities, remains insufficient in the focused research.

Frequently Asked Questions (FAQ)

Common questions about Alergical SF (FAQ)

Q: How quickly does Alergical SF typically start working?

A: Official information indicates that the decongestant component of Alergical SF, pseudoephedrine, can begin to relieve symptoms within about 30 minutes of taking the medication. The onset of action for the antihistamine component, chlorpheniramine, may be slower. The specific time to observe full relief can vary, as noted in clinical data.

Q: How long can I expect the effects of one dose of Alergical SF to last?

A: The expected duration of effect depends on the specific formulation of the medicine. Regulatory data for the components show that the decongestant relief typically lasts between 3 and 8 hours. The antihistamine effect may last longer, sometimes up to 24 hours in certain sustained-release dosage forms. The patient should follow the dosage schedule provided with their specific product.

Q: Are there specific foods or beverages, like fruit juices, that should be avoided when taking Alergical SF?

A: Yes, to ensure the medicine is properly absorbed, official administration guidelines advise against consuming this product with alcohol. Furthermore, certain fruit juices, such as grapefruit, orange, or apple juice, may interfere with the body's absorption of the active ingredients and are generally advised to be avoided according to product labeling.

Q: What should I do if I miss a dose of Alergical SF?

A: If a dose is missed, official administration guidance states that the next scheduled dose should be taken at the regular time. The guidance specifies that the dose should not be doubled to compensate for the missed one, as this could increase the risk of side effects.

Q: Is it possible for Alergical SF to cause stomach upset or nausea?

A: Yes, according to the official safety profile, Alergical SF can cause various gastrointestinal side effects. Nausea and upset stomach are listed among the commonly reported adverse reactions for this medicine.

Q: Can Alergical SF be taken with or without food?

A: Official administration instructions generally state that Alergical SF tablets can be taken either with or without food, but must be taken with water. Specific instructions for other forms of the medicine, such as the oral solution, may differ.

Q: Are there any studies on Alergical SF use during pregnancy or breastfeeding?

A: Regulatory guidance suggests caution and typically advises against the use of Alergical SF during pregnancy, especially in the first trimester. Use during breastfeeding is also generally advised against in official guidance due to concerns that the components could pass into breast milk and potentially decrease milk supply.

Q: What kind of research has been done to support the use of Alergical SF?

A: The medicine’s use is supported primarily by short-term clinical research, typically Randomized Controlled Trials (RCTs). These studies describe patterns of symptomatic relief in the studied populations, such as for seasonal allergies and the common cold. Official data highlights that evidence is limited regarding the effects of continuous long-term use.

Q: Is Alergical SF considered a first-generation or second-generation antihistamine?

A: Alergical SF is a combination product that includes the antihistamine ingredient chlorpheniramine. Medical reference texts published by government agencies classify this specific ingredient as a first-generation antihistamine.

Q: Can Alergical SF cause insomnia or nervousness in some people?

A: Yes, official safety documents list various effects on the nervous system. These include both sleeplessness (which may be described as insomnia) and excitability, which can manifest as feelings of nervousness.

Q: Are there any serious side effects of Alergical SF that I should be aware of?

A: Yes, official regulatory safety information documents the potential for serious adverse events. These include a risk of Hypertensive Crisis (a dangerous rise in blood pressure) and rare, severe reactions such as Ischaemic Colitis or Posterior Reversible Encephalopathy Syndrome (PRES). These warnings emphasize the importance of using the product strictly as directed.

Q: Does Alergical SF interact with antacids, and if so, how?

A: Yes, antacids that contain aluminum or magnesium are documented to interact with Alergical SF. This type of antacid can reduce the absorption of the medicine, which may make it less effective. Regulatory guidance specifies that a minimum separation of two hours between taking Alergical SF and these antacids is required.

Q: Can Alergical SF affect the results of an allergy skin test?

A: The antihistamine component in the medicine can suppress the skin reaction necessary for allergy testing. Official information advises that products containing an antihistamine may need to be stopped several days before a scheduled allergy skin test to ensure accurate results.

Q: Why is Alergical SF sometimes available only with a prescription or behind the counter?

A: This regulation is primarily due to the decongestant component, Pseudoephedrine. The component is subject to federal and state laws, such as the Combat Methamphetamine Epidemic Act, to prevent its misuse in the illicit manufacture of methamphetamine. This results in the medicine being regulated to behind-the-counter or prescription-only status in many jurisdictions.

Q: Can Alergical SF help relieve a cough associated with a cold or allergy?

A: Regulatory indications list the primary targets for Alergical SF as symptoms like sneezing, runny nose, and nasal congestion. While it addresses the underlying causes of fluid and swelling, a cough is not typically listed as a main symptom relief target for this specific combination medicine.

Q: Is there a generic version of Alergical SF available?

A: Since the product contains widely established active ingredients (Chlorpheniramine and Pseudoephedrine), the combination is frequently available in generic formulations.

Q: Does Alergical SF have any anticholinergic effects?

A: Yes, the antihistamine component, Chlorpheniramine, is officially documented as having moderate anticholinergic activity. This means it can affect certain neurotransmitters and contribute to side effects such as dry mouth.

Q: Is there a link between Alergical SF and vision problems or blurred vision?

A: Official safety documents list blurred vision as a possible side effect of the medicine. Sudden or significant changes in vision are noted in regulatory information as requiring medical attention.

Q: What is the difference between Alergical SF and products that only contain an antihistamine?

A: Alergical SF is a Fixed-Dose Combination medicine containing both an antihistamine (to block the allergic response) and a decongestant (Pseudoephedrine, to physically reduce nasal swelling). A product with only an antihistamine would not provide the decongestant action.

Q: Is there a specific time of day that is best for taking Alergical SF?

A: Regulatory documents state that this medicine is typically prescribed for a 'Once Daily (QD)' or 'Twice Daily (BID)' schedule. There is no specific time of day universally identified as optimal. Patients should follow the specific schedule determined by the prescriber or the product label.

Q: What are the different forms or presentations of Alergical SF (e.g., tablet, liquid, drops)?

A: Official product information confirms that Alergical SF is supplied in multiple dosage forms. These typically include Oral Solution, Tablets, and Capsules.

Q: How does the decongestant component in Alergical SF affect the body?

A: The decongestant component, Pseudoephedrine, works by stimulating alpha-adrenergic receptors in the blood vessels in the nasal passages. This causes the vessels to constrict (narrow), leading to a reduction of swelling and overall tissue volume, which helps to clear congestion.

Q: Does Alergical SF have a potential for abuse or misuse?

A: Yes, due to the presence of Pseudoephedrine, the product is subject to regulatory controls and warnings to prevent its misuse and diversion, particularly for the illicit manufacture of methamphetamine.

Q: Why do some people report feeling more energized instead of sleepy after taking this drug?

A: Regulatory documents list both drowsiness and excitability as possible effects on the central nervous system. The decongestant component (Pseudoephedrine) is known to have stimulant properties which can cause some individuals to feel more energized or restless.

Q: What is the mechanism by which Alergical SF treats itchy eyes and sneezing?

A: The antihistamine component, Chlorpheniramine, works by blocking the effects of histamine in the body. Histamine is the chemical released during an allergic reaction that triggers symptoms like itching, watery eyes, and sneezing.

Q: Is it normal to see an empty tablet shell in my stool when taking a sustained-release form of Alergical SF?

A: For some sustained-release (extended-release) formulations, this is a normal, expected occurrence. The outer shell is designed to remain intact while the medicine is absorbed over time and is then designed to pass and be excreted from the body.

How should Alergical SF be stored and disposed of?

Official Storage and Disposal Requirements

The storage and disposal of Alergical SF (Chlorpheniramine/Pseudoephedrine Oral Solution) must adhere strictly to the conditions mandated by regulatory labeling to ensure product stability and safety.

Storage Conditions

Requirement Official Regulatory Statement
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep the solution away from excess heat, moisture, and direct light.
Handling Do not freeze the liquid formulation. The container must be kept tightly closed in its original packaging.
Child Safety Mandatory requirement to keep all medication out of the sight and reach of children.

Disposal Instructions

When the medication is expired or no longer needed, it must be properly discarded. Official guidance requires that individuals ask a healthcare professional or pharmacist how to dispose of any unused product to comply with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Alergical SF found in:

A-Z Index: